Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4281]

ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit

ASCO 2023: Immunotherapy for brain cancer metastases shows clinical benefit

ASCO 2023: Adding ribociclib to hormonal therapy reduces risk of recurrence for people with most common subtype of breast cancer

ASCO 2023: Adding ribociclib to hormonal therapy reduces risk of recurrence for people with most common subtype of...

ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

ASCO 2023: Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with...

Initiative will test new drug combinations guided by tumour biology

Initiative will test new drug combinations guided by tumour biology

NCCN joins collaboration to improve standards in cancer care for vietnam

NCCN joins collaboration to improve standards in cancer care for vietnam

Cancer survivors who quit smoking have 36% lower cardiovascular risk than continuers

Cancer survivors who quit smoking have 36% lower cardiovascular risk than continuers

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

Eliminating gene SRC-3 in immune cells triggers effective long-lasting anti-cancer response

Blocking a key immune protein improves radiation therapy for cancer

Blocking a key immune protein improves radiation therapy for cancer

ASCO 2023: Better sexual health for female patients on endocrine therapy: Strategies across the age spectrum

ASCO 2023: Better sexual health for female patients on endocrine therapy: Strategies across the age spectrum

ASCO 2023: Women with breast cancer shed pounds thanks to telephone-based weight loss program

ASCO 2023: Women with breast cancer shed pounds thanks to telephone-based weight loss program

More from ecancer